Elva Castro-Adan

Juriquilla, QUE, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Similar short-term efficacy of oral levosulpiride and intravitreal ranibizumab in patients with diabetic macular oedema.

Similar short-term efficacy of oral levosulpiride and intravitreal ranibizumab in patients with diabetic macular oedema.

Journal: Eye (London, England)
Published: October 29, 2025

Cardiovascular Safety of VIAN-c4551, an Antiangiogenic Peptide Derived From Vasoinhibin.

Cardiovascular Safety of VIAN-c4551, an Antiangiogenic Peptide Derived From Vasoinhibin.

Journal: Drug development research
Published: April 01, 2025

The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability.

The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability.

Journal: PloS one
Published: December 24, 2024

Vasoinhibin is Generated by the Renin-angiotensin System.

Vasoinhibin is Generated by the Renin-angiotensin System.

Journal: Endocrinology
Published: December 05, 2024

Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema.

Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema.

Journal: Scientific reports
Published: September 18, 2024

Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice.

Dopamine D2 receptor antagonist counteracts hyperglycemia and insulin resistance in diet-induced obese male mice.

Journal: PloS one
Published: October 13, 2023

Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial.

Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial.

Journal: Eye (London, England)
Published: February 04, 2023

Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats.

Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats.

Journal: Journal of neuroendocrinology
Published: October 09, 2021

The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling.

The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling.

Journal: The Journal of biological chemistry
Published: August 03, 2021

Main olfactory bulb reconfiguration by prolonged passive olfactory experience correlates with increased brain-derived neurotrophic factor and improved innate olfaction.

Main olfactory bulb reconfiguration by prolonged passive olfactory experience correlates with increased brain-derived neurotrophic factor and improved innate olfaction.

Journal: The European journal of neuroscience
Published: August 03, 2021

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.

The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide.

Journal: Angiogenesis
Published: March 29, 2021

Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice.

Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice.

Journal: Frontiers in endocrinology
Published: November 13, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026